rhodamine 110 has been researched along with warfarin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebert, W; Schwartz-Albiez, R; Spiess, E; Ulbricht, B | 1 |
| Borra, MT; Denu, JM; Smith, BC | 1 |
2 other study(ies) available for rhodamine 110 and warfarin
| Article | Year |
|---|---|
Quantification of intracellular cathepsin activities in human lung tumor cell lines by flow cytometry.
Topics: 2-Naphthylamine; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cathepsin B; Cathepsin L; Cathepsins; Coumarins; Cysteine Endopeptidases; Endopeptidases; Flow Cytometry; Humans; Indicators and Reagents; Lung Neoplasms; Rhodamines; Substrate Specificity; Tumor Cells, Cultured | 1995 |
Mechanism of human SIRT1 activation by resveratrol.
Topics: Antioxidants; Binding Sites; Binding, Competitive; Cell Cycle; Chromatography, High Pressure Liquid; Coloring Agents; Coumarins; Crystallography, X-Ray; Gene Silencing; Histidine; Histone Deacetylases; Humans; Immunoprecipitation; Kinetics; Models, Chemical; Models, Molecular; Peptides; Protein Binding; Protein Conformation; Resveratrol; Rhodamines; Sirtuin 1; Sirtuin 2; Sirtuins; Stilbenes; Substrate Specificity; Time Factors; Tumor Suppressor Protein p53 | 2005 |